NewYork-Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA.
Amyloid. 2020 Jun;27(2):73-80. doi: 10.1080/13506129.2019.1698417. Epub 2019 Dec 11.
Patients with transthyretin (TTR) cardiac amyloidosis demonstrate cardiac cachexia with progression of their cardiomyopathy, which is characterised by malnutrition and a heightened inflammatory state. How best to measure this condition is less well characterised. We investigated differences in survival among patients with ATTR cardiac amyloidosis by nutritional status as defined by modified BMI (mBMI) and by inflammatory state as defined by serum uric acid. This study was a retrospective analysis of patients diagnosed with ATTR cardiac amyloidosis at a single tertiary medical centre. Baseline characteristics were compared by nutritional status as measured by mBMI and by inflammatory state as measured by serum uric acid. Kaplan-Meier survival analyses were used to compare nutritional status and inflammatory status for the composite outcome of death. Cox proportional hazards modelling was used to assess predictors of death in this cohort. Three hundred patients (mean age 75 ± 11) years, 84.3% male) were included. Those with low mBMI (<1185 kg/m g/L) had shorter time to death (5.4 vs. 6.8 years, log rank = .045) and those with elevated serum uric acid (>8.8 mg/dL) had shorter time to death (4.9 vs. 7.7 years, log rank < .0001). Those with both low mBMI and elevated serum uric acid had the shortest time to death (4.3 years, log rank = .005). In this cohort, mBMI was not a univariate predictor of death though there was a trend towards significance (HR 0.92, per 100 kg/m g/L, 95% CI 0.828-1.016, = .099). Serum uric acid was a univariate predictor of death (HR 1.27 per 1 mg/dL, 95% CI 1.114-1.455, < .001). In multivariate Cox analysis, this association remained significant (HR 1.31 per 1 mg/dL increase, 95% CI 1.096-1.560, = .003) as well as in a separate stepwise model controlling for potential confounders including daily diuretic use, uric acid lowering therapy, and renal dysfunction. Both nutritional status as measured by mBMI and inflammation as measured by serum uric acid are associated with survival in patients with TTR cardiac amyloidosis however only serum uric acid is an independent predictor of death.
转甲状腺素蛋白(TTR)心脏淀粉样变性患者随着心肌病的进展表现出心脏恶病质,其特征为营养不良和炎症状态增强。如何最好地衡量这种情况还不太清楚。我们通过改良 BMI(mBMI)定义的营养状况和通过血清尿酸定义的炎症状态,研究了ATTR 心脏淀粉样变性患者之间的生存差异。这项研究是对单个三级医疗中心诊断为ATTR 心脏淀粉样变性的患者进行的回顾性分析。通过 mBMI 测量的营养状况和通过血清尿酸测量的炎症状态来比较基线特征。使用 Kaplan-Meier 生存分析比较营养状况和炎症状态对死亡的复合结局。使用 Cox 比例风险模型评估该队列中死亡的预测因素。共纳入 300 例患者(平均年龄 75±11 岁,84.3%为男性)。mBMI 较低(<1185kg/m g/L)的患者死亡时间更短(5.4 与 6.8 年,对数秩检验 = .045),血清尿酸升高(>8.8mg/dL)的患者死亡时间更短(4.9 与 7.7 年,对数秩检验 < .0001)。同时 mBMI 低和血清尿酸升高的患者死亡时间最短(4.3 年,对数秩检验 = .005)。在该队列中,尽管 mBMI 是死亡的单因素预测因素,但趋势有统计学意义(每 100kg/m g/L 风险比 0.92,95%CI 0.828-1.016, = .099)。血清尿酸是死亡的单因素预测因素(每增加 1mg/dL 的风险比 1.27,95%CI 1.114-1.455, < .001)。在多变量 Cox 分析中,这种相关性仍然显著(每增加 1mg/dL 血清尿酸的风险比 1.31,95%CI 1.096-1.560, = .003),在单独的逐步模型中也是如此,该模型控制了包括每日利尿剂使用、尿酸降低治疗和肾功能障碍在内的潜在混杂因素。mBMI 衡量的营养状况和血清尿酸衡量的炎症状态均与 TTR 心脏淀粉样变性患者的生存相关,但只有血清尿酸是死亡的独立预测因素。